SCHEMBL13660784

SCHEMBL13660784

COC(=O)CN(C1CCc2ccccc21)S(=O)(=O)c1ccc(Cl)cc1Cl

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BDKRB1 P46663 4/20 0.42
PDE4A P27815 4/20 0.42
PDE4B Q07343 4/20 0.42
PDE4C Q08493 4/20 0.42
PDE4D Q08499 4/20 0.42
PYGL P06737 1/20 0.40
F10 P00742 1/20 0.39
TAS2R14 Q9NYV8 1/20 0.38
KCNA5 P22460 1/20 0.38
TAS1R3 Q7RTX0 1/20 0.38
TAS1R1 Q7RTX1 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
PER2 O15055 1/20 0.38
CRY1 Q16526 1/20 0.38
CRY2 Q49AN0 1/20 0.38
ALDH1A1 P00352 1/20 0.38
RORC P51449 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13660783 0.83 PYGL (0.47) BDKRB1PDE4APDE4BPDE4CPDE4D
SCHEMBL13660787 0.80 PDE4A (0.39) BDKRB1PDE4APDE4BPDE4CPDE4D
SCHEMBL4293197 0.80 PDE4A (0.40) BDKRB1PDE4APDE4BPDE4CPDE4D
SCHEMBL13660777 0.70 TRPV4 (0.47) BDKRB1TAS1R3TAS1R1ALDH1A1
SCHEMBL13660786 0.67 CA1 (0.58) PDE4APDE4BPDE4CPDE4DKCNA5
SCHEMBL485400 0.66 HTR2A (0.45) TAS1R3TAS1R1ALDH1A1KMT2A
SCHEMBL13209090 0.66 ALDH1A1 (0.57) TAS2R14ALDH1A1KMT2A
SCHEMBL7422584 0.65 PDE4A (0.73) PDE4APDE4BPDE4CPDE4DTAS2R14
SCHEMBL9493177 0.63 ALDH1A1 (0.51) TAS2R14TAS1R3TAS1R1ALDH1A1KMT2A
SCHEMBL9493484 0.63 ALDH1A1 (0.51) TAS2R14TAS1R3TAS1R1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8318769-B2 Substituted sulfonamide compounds GRUENETHAL GMBH (DE) 2012-11-27 US disclosed
US-8318769-B2 Substituted sulfonamide compounds GRUENETHAL GMBH (DE) 2012-11-27 US disclosed
US-20090264400-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-10-22 US disclosed
US-20090264400-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-10-22 US disclosed
WO-2009124733-A1 SUBSTITUTED SULFONAMIDE DERIVATIVES GRUENENTHAL GMBH (DE) 2009-10-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264400-A1 Substituted Sulfonamide Compounds BDKRB1, BDKRB2, TRPV1 BDKRB1 1/4885PDE4A 2233/4885PDE4B 2812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.